Medtronic acquires SPR Therapeutics for $650 million
Tweet Send to a Friend
Medtronic plc (NYSE: MDT) announced it has completed the acquisition of SPR Therapeutics, Inc., a privately held medical technology company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


